← Eichor
Condition: Liver Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Liver

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195
Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565
Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk R
Phase 2 · 4 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07239245
Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Li
Phase N/A · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07652892
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05185245
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Phase N/A · 1 location(s) · Steno Diabetes Center Copenhagen · NCT05890365
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881
Prospective Comparative Validation Study of RUCAM and RECAM
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT06771011
Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07612163
Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians
Phase N/A · 1 location(s) · Novo Nordisk A/S · NCT07682363
ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of
NA · 1 location(s) · Institute for Clinical and Experimental Medicine · NCT07329036
CapTemY90 for Grade 2/3 NET Liver Metastases
Phase 2 · 4 location(s) · Abramson Cancer Center at Penn Medicine · NCT04339036
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in
Phase N/A · 1 location(s) · Sohag University · NCT06953921
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NA · 2 location(s) · University of Pennsylvania · NCT06136221
Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT02838836
A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear S
Phase 3 · 1 location(s) · Huahui Health · NCT07499544
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
Phase N/A · 10 location(s) · Astellas Gene Therapies · NCT06581146
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
Phase N/A · 1 location(s) · National Cancer Institute, Naples · NCT06905262
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the
Phase 2 · 10 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07549503
BeijngFH Health Cohort Study
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT05546086
Effect of Preoperative CIMT on Hemodynamics During Liver Transplantation
Phase N/A · 1 location(s) · Dicle University · NCT07660679
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06571396
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT06333561
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Phase N/A · 1 location(s) · University of Chicago · NCT05264051
Biliary Fistulas in Surgery of Liver Echinococcosis
NA · 1 location(s) · Republican Specialized Scientific and Practical Medical Cent · NCT06612229
TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases
NA · 1 location(s) · Niguarda Hospital · NCT07607873
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06389422
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.